Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 3 art units • 3 examiners • 0 of 6 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Sydnexis, Inc. currently has 6 pending office actions within the Biotechnology & Pharmaceuticals technology area. The prosecution of these applications is distributed across 3 distinct examiners and 3 distinct art units. This distribution suggests that the company's pending matters are subject to the varying standards and examination styles of multiple administrative units within the patent office.
Examiner LEE, WILLIAM Y is the busiest examiner for the portfolio, overseeing 4 pending office actions. This concentration means that while there are 3 distinct examiners involved, a high volume of the 6 pending office actions is being reviewed by a single individual. This makes the relationship with this specific examiner critical to the portfolio's overall success. While the remaining actions are handled by other distinct examiners, the reliance on this examiner within the 3 distinct art units highlights a focal point in the company's current prosecution landscape.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (67%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 1 (17%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LEE, WILLIAM Y | 4 | 47.9% | +34.1% |
| KALIHER, HANS CHRISTIAN | 1 | 62.9% | +27.3% |
| TRAN, ERIC | 1 | 70.8% | +23.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18763381 | OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF | KALIHER, HANS CHRISTIAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18784718 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | 10d overdue |
| 17721831 | OPHTHALMIC COMPOSITION | TRAN, ERIC | 8d overdue |
| 17894884 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | 55d |
| 18763381 | OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF | KALIHER, HANS CHRISTIAN | — |
| 17894882 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | — |
| 17894885 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | — |
| Art Unit | Apps |
|---|---|
| 1623 | 4 |
| 3781 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18784718 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | 1623 | §103 | Final Rejection | 10d overdue | Pending | Jul 25, 2024 |
| 18763381 | OPHTHALMIC COMPOSITION AND DELIVERY DEVICE THEREOF | KALIHER, HANS CHRISTIAN | 3781 | §103§112 | Final Rejection | — | Pending | Jul 03, 2024 |
| 17894882 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | 1623 | §103Other | Final Rejection | — | Pending | Aug 24, 2022 |
| 17894885 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | 1623 | §103DP | Final Rejection | — | Pending | Aug 24, 2022 |
| 17894884 | OPHTHALMIC COMPOSITION | LEE, WILLIAM Y | 1623 | §103Other | Final Rejection | 55d | Pending | Aug 24, 2022 |
| 17721831 | OPHTHALMIC COMPOSITION | TRAN, ERIC | 1629 | §103 | Non-Final OA | 8d overdue | Pending | Apr 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial